Heart : official journal of the British Cardiac Society
-
Multicenter Study Comparative Study
Mid-regional proatrial natriuretic peptide for predicting prognosis in hypertrophic cardiomyopathy.
N-terminal probrain natriuretic peptide (NT-proBNP) predicts mortality and the development of heart failure in hypertrophic cardiomyopathy (HCM). Mid-regional proatrial natriuretic peptide (MR-proANP) is a stable by-product of production of atrial natriuretic peptide. We sought to compare the prognostic value of MR-proANP and NT-proBNP in HCM. ⋯ MR-proANP emerges as a valuable biomarker for the prediction of death and heart failure related events in patients with HCM.